Dieter Ayers Selected Research

Dieter Ayers Research Topics

5	Septic Shock (Toxic Shock Syndrome) 01/2017 - 02/2008
4	Multiple Myeloma 11/2023 - 10/2021
3	Neoplasms (Cancer) 01/2022 - 01/2019
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2021 - 01/2021
3	Ischemia 01/2017 - 09/2011
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Fabry Disease (Fabry's Disease) 04/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Chagas Disease (American Trypanosomiasis) 12/2016
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2013
1	Hypothyroidism 08/2013
1	Necrosis 06/2013
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2011
1	Acidosis 06/2011
1	Anemia 06/2011
1	Acute Kidney Injury (Acute Renal Failure) 01/2010
1	Renal Insufficiency (Renal Failure) 01/2010

5	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2017 - 02/2008
5	Vasopressins (Vasopressin)IBA 01/2017 - 02/2008
4	idecabtagene vicleucelIBA 11/2023 - 10/2021
3	Chimeric Antigen ReceptorsIBA 10/2022 - 01/2019
3	cemiplimabIBA 11/2021 - 01/2021
2	belantamab mafodotinIBA 11/2023 - 10/2021
2	NivolumabIBA 01/2020 - 01/2019
2	TroponinIBA 06/2013 - 09/2011
1	pembrolizumabIBA 11/2021
1	Proteasome InhibitorsIBA 10/2021
1	agalsidase beta FDA Link 04/2021
1	amrubicinIBA 01/2019
1	tisagenlecleucelIBA 01/2019
1	IpilimumabIBA 01/2019
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2019
1	Liraglutide FDA Link 01/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2017
1	benzonidazole (benznidazole)IBA 12/2016
1	A 7 (A-7)IBA 08/2013
1	Glucagon (Glukagon)FDA Link 08/2013
1	Hemoglobins (Hemoglobin)IBA 08/2013
1	Troponin IIBA 06/2013
1	Biomarkers (Surrogate Marker)IBA 06/2013
1	MineralsIBA 06/2011
1	CatecholaminesIBA 02/2008

5	Therapeutics 10/2022 - 10/2017
1	Drug Therapy (Chemotherapy) 01/2019
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2010